Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have obesity, measured using BMI and waist size based on sex and ethnic-specific guidelines
- Adults aged 18 years or older
- People with high blood pressure, with a top (systolic) reading between 120 and 160 mmHg
- People who have been on stable medication for blood pressure, blood sugar, cholesterol, or weight management for at least 3 months
- People who are not planning to start a new weight loss program during the trial
- Approximately half of participants will need to have type 2 diabetes with a blood sugar control measurement (HbA1c) between 6.5% and 9.0%
Who may not be able to join:
- People who have had a stroke or heart attack in the past year
- People with a type 1 diabetes diagnosis
- People who have lost or gained 5% or more of their body weight in the past 6 months
- People currently using insulin
- People with an eating disorder or substance use disorder
- People with serious depression or other psychiatric conditions
- People who have had bariatric surgery or any surgery within the past 6 months
- People with uncontrolled high blood pressure (top reading above 160 mmHg or bottom reading above 100 mmHg)
- People who experience chest pain (angina)
- People with certain digestive conditions such as inflammatory bowel disease or celiac disease, pancreatitis, chronic kidney or liver disease, significant heart conditions, or a major ongoing disability or disorder requiring continuous medical care
- People regularly taking certain herbal supplements or other supplements that could affect the trial's main results (confirm with trial site)
- People who drink more than 3 alcoholic drinks per day, or who are currently participating in another clinical trial
- People with allergies or intolerances to soy
- People with allergies or intolerances to all three of the following: tree nuts, peanuts, and seeds
- People regularly taking certain medications including high-dose prescription anti-inflammatory drugs (NSAIDs), antacids, warfarin, or medications that affect a body process called NO synthesis (such as sildenafil or nitrates)
- People with an active or chronic infection such as HIV, tuberculosis, or COVID-19, or other chronic inflammatory infections
- People with a chronic inflammatory condition such as rheumatoid arthritis
- People who have used antibiotics within 3 months before the trial starts
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 416-946-0579
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Systolic Blood Pressure
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.